质子疗法使5年的存活率提高到90.9%,并减少了对高级头部和颈部癌症患者的副作用,这是一项重大试验。 Proton therapy boosted 5-year survival to 90.9% and reduced side effects in advanced head and neck cancer patients, a major trial found.

一位美国大人物 A major U. S. A major U.S. 涉及440名高头癌和颈癌患者的第三阶段试验发现,质子治疗5年期存活率提高至90.9%,而传统辐射为81%,以及干口、吞咽困难和食管依赖性等严重副作用减少。 Phase III trial involving 440 patients with advanced head and neck cancer found proton therapy improved 5-year survival rates to 90.9% compared to 81% with traditional radiation, along with fewer severe side effects like dry mouth, swallowing difficulties, and feeding tube dependence. 该研究在21个地点进行,由MD Anderson癌症中心牵头,支持质子治疗,因为其精确地针对肿瘤,同时保留健康组织,因此是治疗奥氏性肿瘤的较高标准。 Conducted at 21 sites and led by MD Anderson Cancer Center, the study supports proton therapy as a superior standard of care for oropharyngeal cancer due to its precision in targeting tumors while sparing healthy tissue.